Statistics for Medicenna Therapeutics Corp (id:13790 MDNA)

Valuation metrics

Market cap

134.52M

Enterprise value

123.34M

Trailing P/E (ttm)

-4.03

Forward P/E

-7.65

PEG ratio

-7.65

Price/Sales (ttm)

Price/Book (mrq)

5.89

Enterprise Value/Revenue

Enterprise Value/EBITDA

-6.76

Overview

Shares outstanding

76.43M

Float

49.80M

Shares short

33.71K

% Held by insiders

0.23%

% Held by institutions

0.13%

Average volume (10 days)

155.50K

Average volume (90 days)

Price summary

52-Week low

0.38

52-Week high

2.98

52-Week change

68.12%

Beta

1.19

50-Day moving average

2.19

200-Day moving average

1.91

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

March 03th, 2017

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

March 31th, 2024

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-32.80%

Return on equity

-105.43%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-18,247,000.00

Net income to common (ttm)

-26,241,000.00

Diluted EPS (ttm)

-0.38

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

35.63M

Total cash per share (mrq)

0.46

Total debt (mrq)

0.00

Total Debt/Equity (mrq)

0.00

Current ratio (mrq)

250.50%

Book value per share (mrq)

0.30

Cash flow

Cash flow statement

-15,120,000.00

Levered free cash flow (LFCF)

-30,375.00